We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

By LabMedica International staff writers
Posted on 24 Sep 2026

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. More...

Although PCR is central to case detection, contamination during specimen collection or processing can produce misleading results and affect surveillance and patient management. New findings from the Democratic Republic of the Congo (DRC) show that many mpox PCR-positive results reflected environmental contamination rather than true infection.

The University of Geneva (UNIGE), together with the Institute of Tropical Medicine Antwerp and the National Institute of Biomedical Research in the DRC, analyzed more than 2,700 mpox PCR results from Goma, Kamituga, Kinshasa, and Uvira collected between April 2024 and April 2026. The analysis, published in The Lancet Infectious Diseases on September 15, 2026, indicates that 35% of results reported as PCR-positive likely reflected environmental contamination with mpox viral DNA rather than active infection. The work has implications for outbreak monitoring and individual patient management.

The team examined cycle threshold (CT) values, which are inversely related to the amount of target DNA detected by PCR. Rather than forming a single distribution, CT values consistently separated into two clusters across study sites: one with low CT values consistent with high viral loads and another near the assay’s detection limit. To investigate whether contamination could explain the borderline results, researchers swabbed surfaces within treatment areas at two care centers. Mpox DNA was frequently detected on surfaces inside these areas but not on those outside them, supporting environmental contamination as a likely source of some positive results.

Serological findings further supported this interpretation. Among individuals the model classified as likely false positives, 89% had no detectable antibodies to mpox. In a separate, smaller assessment of patients with suspected mpox, most were found to have other viruses associated with rash, including varicella (chickenpox) and measles, while few tested positive for mpox. The Geneva Center for Emerging Viral Diseases, a World Health Organization collaborating center for diagnostics, contributed to the study and supports countries in strengthening diagnostic practices.

“The first group corresponds to low values, consistent with a high viral load and therefore a genuine active infection. The second cluster sat just at the detection threshold, pointing to an extremely low viral load — atypical for a real infection, but typical of a residual viral trace. What’s striking is that this clear split between the two groups appeared almost identically across all four sites, which is unlikely to be a coincidence,” said Andrew Azman, associate professor at the Institute of Global Health and the Center for Emerging Viral Diseases at the UNIGE Faculty of Medicine.

“The simplest and fastest fix is to lower the PCR positivity threshold. A lower threshold significantly reduces the number of false positives without meaningfully increasing false negatives — a proposal currently under discussion with decision-makers. In the long term, this shows that we need to improve the training of lab staff in low-resource settings like this so they can spot these anomalies in real time, rather than after the acute emergency is over,” added Azman.

Related Links
UNIGE


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.